| 2006 年 | 2007 年 | 2008 年 | 2009 年 | 2010 年 |
| 2011 年 | 2012 年 | 2013年 | 2014年 | 2015年 |
| 2016 年 | 2017 年 | 2018 年 | 2019 年 | 2020 年 |
| 2021 年 | 2022 年 | 2023 年 | 2024 年 |
※ 英文原著論文のみ掲載しています。
【 2018年 】
- Fujii H, Kono K, Nakai K, Goto S, Nishii T, Kono A, Nishi S.
Effects of lanthanum carbonate on coronary artery calcification and cardiac abnormalities after initiating hemodialysis.
Calcif Tissue Int. 2018; 102(3): 310-320. - Watanabe K, Fujii H, Goto S, Nakai K, Kono K, Watanabe S, Shinohara M, Nishi S.
Newly developed rat model of chronic kidney disease-mineral bone disorder.
J Atheroscler Thromb. 2018; 25(2): 170-177. - Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T.
Nationwide multicenter kidney biopsy study of Japanese patients with type 2 diabetes.
Nephrol Dial Transplant. 2018; 33(1): 138-148. - Fujii H, Goto S, Fukagawa M.
Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
Toxins. 2018;10(5). pii: E202. - Fujii H.
Association between parathyroid hormone and cardiovascular disease.
Ther Apher Dial. 2018; 22(3): 236-241. - Isaka Y, Fujii H, Tsujimoto Y, Teramukai S, Hamano T.
Rationale, design, and characteristics of a trial to evaluate the new phosphate iron-based binder sucroferric oxyhydrodide in dialysis patients with the goal of advancing the practice of E.B.M. (EPISODE).
Clin Exp Nephrol. 2018; 22(4): 967-972. - Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.
Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.
Clin Exp Nephrol. 2018; 22(3): 570-582. - Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.
Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis.
Clin Exp Nephrol. 2018; 22(3): 629-637. - Kubota W, Honda M, Okada H, Hattori M, Iwano M, Akioka Y, Ashida A, Kawasaki Y, Kiyomoto H, Sako M, Terada Y, Hirano D, Fujieda M, Fujimoto S, Masaki T, Ito S, Uemura O, Gotoh Y, Komatsu Y, Nishi S, Maru M, Narita I, Maruyama S.
A consensus statement on health-care transition of patients with childhood-onset chronic kidney diseases: providing adequate medical care in adolescence and young adulthood.
Clin Exp Nephrol. 2018;22(4):743-751. - Fujii H, Watanabe K, Kono K, Goto S, Watanabe S, Nishi S.
Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats.
Clin Exp Nephrol. 2018 [Epub ahead of print] - Nishi S, Hoshino J, Yamamoto S, Goto S, Fujii H, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y.
Multicentre cross-sectional study for bone- articular lesions associated with dialysis related amyloidosis in Japan.
Nephrology (Carlton). 23: 640-645, 2018. - Hyogo Y, Kiyota N, Otsuki N, Goto S, Imamura Y, Chayahara N, Toyoda M, Nibu KI, Hyodo T, Hara S, Masuoka H, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.
Case Rep Oncol. 11: 735-741, 2018. - J-DAVID Investigators, Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y.
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis:The J-DAVID Randomized Clinical Trial.
JAMA. 320: 2325-2334,2018. - Unzaki A, Morisada N, Nozu K, Ye MJ, Ito S, Matsunaga T, Ishikura K, Ina S, Nagatani K, Okamoto T, Inaba Y, Ito N, Igarashi T, Kanda S, Ito K, Omune K, Iwaki T, Ueno K, Yahata M, Ohtsuka Y, Nishi E, Takahashi N, Ishikawa T, Goto S, Okamoto N, Iijima K.
Clinically diverse phenotypes and genotypes of patients with branchio-oto-renal syndrome.
J Hum Genet. 63: 647-656, 2018. - Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y,
Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Clin Exp Nephrol. 22: 1266-1280, 2018.
